Longboat
Longboat (now Advarra Study Collaboration) is a cloud-based clinical trial collaboration platform that provides secure document exchange, AI-enabled training, and SSO-based access for pharma sponsors, CROs, and investigator sites. Acquired by Advarra in 2026.
- Company typePrivate
- Founded2022
- HeadquartersDublin, Ireland
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Longboat does
Longboat is a cloud-based clinical trial collaboration platform that enables pharmaceutical sponsors, biotech companies, contract research organizations (CROs), and investigator sites to coordinate training, document exchange, and study operations through a unified portal (app.longboat.com). The company's core product, now marketed as "Advarra Study Collaboration" following its acquisition, combines AI-enabled training modules, single sign-on (SSO) authentication, secure messaging, and auditable document exchange with automated routing to electronic Trial Master File (eTMF) systems. Technically, the platform integrates with site-owned eISF/eReg systems, Medidata's iMedidata login, and leverages Advarra's Braid data and AI engine for operational intelligence.
Longboat monetizes through an enterprise SaaS subscription model, sold primarily via direct field sales to large pharma sponsors, CROs, and research sites, with a self-serve portal enabling site-level onboarding. The company originated in Dublin, Ireland and operates with 51-100 employees, though its legal entity is U.S.-domiciled. In 2026, Longboat was acquired by Advarra, a clinical research services provider with deep IRB and regulatory capabilities, and the product was rebranded as Advarra Study Collaboration while retaining the longboat.com domain. As part of the Advarra ecosystem, the platform benefits from cross-selling opportunities across Advarra's portfolio of IRB, site solutions, and compliance products.
Longboat firmographics
Firmographics- Name
- Longboat
- Legal name
- Longboat
- Website
- https://longboat.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- Longboat (now Advarra Study Collaboration) is a cloud-based clinical trial collaboration platform that provides secure document exchange, AI-enabled training, and SSO-based access for pharma sponsors, CROs, and investigator sites. Acquired by Advarra in 2026.
- Ownership category
- akta.pro rank
Longboat industry classification
Industry- Product category
- Clinical Trial Collaboration Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Enterprise Work Management & Collaborative Workflow Platforms (HDAEAHAI)
Keywords
Where Longboat is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Markets served
Longboat business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform Subscription (SaaS): Advarra Study Collaboration (Longboat) operates as a cloud-based SaaS platform on a subscription model, providing access to site collaboration, training, and document management tools on a per-seat or site license basis. The subscription model is typical for enterprise clinical trial software serving pharma sponsors, CROs, and research sites.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Longboat product offering
Product offeringCore offering
Longboat (now Advarra Study Collaboration) is a cloud-based clinical trial collaboration platform that enables secure document exchange, AI-powered study training, and centralized single sign-on access for sites, sponsors, and CROs. The platform centralizes site collaboration, training management, and auditable document workflows to streamline study startup and regulatory compliance across distributed clinical trial stakeholders.
Differentiator
Problem solved
Functional benefit
Products and services
- Study Collaboration (fka Longboat)
Companies that use Longboat
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Longboat technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature4 records
Longboat partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medidata (Dassault Systèmes)coreAdvarra Study Collaboration (Longboat) integrates with the Medidata platform via iMedidata login, enabling users to authenticate through Medidata's identity layer. This integration positions the platform within the Medidata clinical trial ecosystem, allowing joint customers to access Longboat tools directly through their Medidata portal environment.
Recent moves3 records
Expansion highlights5 records
Longboat competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Veeva provides the Vault Clinical Suite (CTMS, eTMF, eRegulatory) widely adopted across pharma sponsors and CROs. Its eTMF, eRegulatory, and Vault Study Collaboration capabilities directly overlap with Advarra Study Collaboration in serving sponsor/CRO/site document and workflow needs, making it the most comparable broad incumbent.
- IQVIA (Digital Trial Management / DrugDev): IQVIA, which acquired DrugDev, offers site feasibility, site payments, and investigator portal capabilities within its broader CRO and technology stack. Its site-centric tools overlap with Longboat's collaboration and training offering, particularly for large sponsor customers seeking a single-vendor technology suite.
- Oracle Health Sciences (Clinical One): Oracle Health Sciences provides Clinical One, a unified clinical trial platform spanning EDC, RTSM, supply management, and trial conduct. Its scale and sponsor relationships make it a broad incumbent competing for the same site-collaboration and study-conduct workflow budget that Longboat addresses.
- Advarra (parent): Advarra is the parent company of Longboat and offers IRB, IBC, DMC, GxP compliance, and broader site solutions (OnCore CTMS, Clinical Conductor, eReg, eSource). Its institutional research site portfolio overlaps with Longboat's customer base and provides the regulatory and distribution backbone within which Study Collaboration operates.
Direct peers
- Medidata (Dassault Systèmes): Medidata's Rave Clinical Cloud (EDC, eCOA, RTSM, Decentralized Trials) and its iMedidata SSO layer are the primary integration partner for Longboat. It is also a competitor in site-facing trial technology, with overlapping capabilities in study training, document exchange, and centralized access for investigator sites.
- Signant Health: Signant Health (formed from the merger of CRF Health and Bracket) provides eCOA, ePRO, patient engagement, and site-facing clinical technology solutions. Its SmartSignals and Patient Cloud suites compete directly with Longboat in study training, site collaboration, and digital data capture within clinical trials.
- Florence Healthcare: Florence Healthcare provides eBinders (eISF) and eTMF platforms used by research sites and sponsors for document management and regulatory compliance. Its site-centric document workflow overlaps directly with Longboat's secure document exchange and eRegulatory integrations.
- Clinical Ink: Clinical Ink provides eCOA, ePRO, and site-facing digital data capture tools for clinical trials, including site workflow and document management capabilities. Its focus on site staff experience and protocol compliance is closely aligned with Longboat's training and collaboration focus.
- Veeva Vault CTMS: Veeva Vault CTMS and its associated study startup and site management modules are a direct comparable for clinical operations workflow, site activation, and document exchange within the Vault platform. It is the closest direct functional peer to Longboat's site collaboration suite.
Emerging players
- Castor EDC: Castor offers a cloud-based eClinical platform including EDC, ePRO, eConsent, and decentralized trial capabilities with strong site UX emphasis. It serves as an emerging alternative in the broader site-collaboration and trial data management category where Longboat operates.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Longboat social profiles
Digital presenceLongboat financial estimates
Financial estimateRevenue estimate
Valuation estimate
Longboat leadership team
Management profileNumber of profiles
Longboat funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Longboat M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Longboat
What does Longboat do?
Longboat (now Advarra Study Collaboration) is a cloud-based clinical trial collaboration platform that enables secure document exchange, AI-powered study training, and centralized single sign-on access for sites, sponsors, and CROs. The platform centralizes site collaboration, training management, and auditable document workflows to streamline study startup and regulatory compliance across distributed clinical trial stakeholders.
Is Longboat a public or private company?
Longboat is a private company. It is classified as corporate owned and is currently acquired.
When was Longboat founded?
Longboat was founded in 2022. It employs 51 to 100 people.
Where is Longboat based?
Longboat is headquartered in Dublin, Ireland, in the Europe region.
How does Longboat make money?
One revenue line is on record: platform Subscription (SaaS).
Who are Longboat's main competitors?
Broad incumbents on record are Veeva Systems, IQVIA (Digital Trial Management / DrugDev), Oracle Health Sciences (Clinical One) and Advarra (parent). Direct peers are Medidata (Dassault Systèmes), Signant Health, Florence Healthcare, Clinical Ink and Veeva Vault CTMS. Castor EDC is listed as an emerging player.
Does Longboat have an API?
No public API is recorded for Longboat.
What industry is Longboat in?
Longboat's product category is Clinical Trial Collaboration Software. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 513210 and its SIC code is 7372.